Compounding pharmacies, explained

Start here

CompoundingHow to choose a quality peptide compounding pharmacy: the quality signalsCompoundingWhat PCAB accreditation means for compounding pharmacy qualityCompoundingWhat telehealth peptide prescribing actually looks likeCompoundingUSP 795 vs USP 797: the two compounding standards a quality pharmacy followsCompoundingVial coring: what it is and how to prevent it

All compounding guides (61)

• 503A Compounding FAQ: The Questions Patients and Prescribers Ask

  503A pharmacies compound medications for individual prescriptions under state license. Here are direct answers to the most common questions about how they work.

• 503A compounding pharmacies: what they are and how they work

  503A compounding pharmacies in plain English — what they do, how they differ from a regular drugstore, the FDA framework that authorizes them, and why they matter for peptide care.

• 503A compounding risks: what the 2012–2013 incidents taught us

  503A compounding risks in plain English: what the 2012 NECC outbreak revealed, the reforms that followed, and how a careful 503A pharmacy mitigates risk today.

• 503A compounding vs commercial manufacturing: what is different

  503A compounding makes patient-specific doses under USP standards, not FDA-approved mass batches. FDA does not review compounded drugs for safety, effectiveness, or quality. Learn how it differs from commercial drug manufacturing.

• 503A pharmacy quality standards: what to look for

  503A pharmacy quality standards in plain English: USP-797 sterility, PCAB accreditation, certificate of analysis, and licensed-state pharmacist oversight. What to ask before you fill.

• 503A vs 503B compounding pharmacies explained

  503A pharmacies fill patient-specific prescriptions. 503B outsourcing facilities supply providers at scale. Here's what each means for your compounded peptide prescription.

• 503A vs 503B compounding: the functional difference

  503A and 503B compounding pharmacies are both legal, but they serve different patients in different ways. Here is the practical difference in plain English.

• API standards: what goes into a compounded peptide

  The API is the active ingredient inside a compounded peptide. Here is what quality standards apply, why source matters, and how to think about it, plainly.

• Beyond the shortage: why compounded peptides still have a role

  The drug shortage designation that opened the door to compounded GLP-1s has changed. Here's what that means for compounded peptides — and what hasn't changed at all.

• Beyond-use dating: how long a compounded medication stays good

  A beyond-use date tells you how long a compounded medication remains usable. Here is what it means, how it differs from an expiration date, and why it matters.

• Compounding Pharmacy Quality: A History of Oversight

  Compounding pharmacy oversight changed after the 2012 NECC outbreak. The 2013 DQSA created the 503A and 503B framework that governs quality today.

• Compounding pharmacy quality: the difference between USP-795 and USP-797

  USP-795 vs USP-797 explained in plain English: the two standards that govern compounding pharmacy quality, and why injectable peptides require the stricter one.

• Compounding Quality FAQ: The Pharmacy Standards Questions Answered

  What actually keeps a compounding pharmacy safe? Direct answers on USP standards, PCAB accreditation, inspections, and how to check quality yourself.

• Depyrogenation: how pyrogens are removed from injectables

  Depyrogenation destroys fever-causing endotoxins on injectable equipment. See how baking glass at 250°C for 30 minutes works and why it goes beyond sterility.

• Endotoxin testing: the safety check beyond sterility

  Endotoxin testing checks injectables for bacterial toxins that survive sterilization. See how the LAL test works and what to look for on a lab certificate.

• Endotoxin testing: why compounded injectables are screened for pyrogens

  Endotoxin testing checks injectables for fever-causing bacterial fragments. Here is what pyrogens are, how the test works, and why sterile is not enough.

• Gray-market peptides: why third-party testing isn't enough

  Gray-market peptide sellers often claim third-party testing proves their products are safe. Here's why that claim doesn't hold up — and what actually matters.

• Gray-market research peptides: the quality risk explained

  Research-only peptides sold online skip the checks a licensed pharmacy must pass. Here is the plain-English quality risk that the lower price actually creates.

• Gray-market research-use-only peptides: the real risk profile

  RUO-labeled peptides are not intended for human use. No purity guarantees, no sterility testing, no dosing standards. Here's what the FDA and published literature say.

• How 503A pharmacies compound peptides from API to vial

  A 503A pharmacy turns a prescription into a finished peptide vial. Here's the step-by-step look at how that happens — API to vial, plainly explained.

• How compounded peptides are made: API to vial

  How does a compounding pharmacy actually make a peptide vial? A plain-English walk through API sourcing, sterile compounding, fill-finish, and quality testing.

• How PCAB Evaluates Compounding Pharmacy Quality

  PCAB reviews compounding pharmacies against USP standards, staff training, and facility controls through document review plus an on-site survey.

• How to choose a quality peptide compounding pharmacy: the quality signals

  How to choose a compounding pharmacy: check its state license, USP 797 and 800 compliance, PCAB accreditation and paperwork. Five signals and what to ask.

• How to evaluate a 503A compounding pharmacy: the checklist

  A plain-English checklist for evaluating a 503A compounding pharmacy: licensing, accreditation, sourcing, and the questions worth asking before you trust one.

• How to evaluate a compounding pharmacy before you fill a prescription

  How to evaluate a compounding pharmacy: check state licensing, 503A or 503B status, PCAB accreditation, third-party testing, and FDA inspection history.

• How to read a peptide COA: what third-party lab results really tell you

  A peptide COA looks reassuring, but it only proves so much. Here's how to read a certificate of analysis and what it can't tell you, in plain English.

• Particulate inspection: why vials are checked against light

  Particulate inspection is the visual check that screens injectable vials for stray particles. Here is how it works and why it protects patients.

• PCAB accreditation explained: what it means for a compounding pharmacy

  PCAB accreditation is a voluntary verification that a compounding pharmacy meets specific quality standards. Here is what it covers — and what it doesn't replace.

• PCAB Accreditation Research: What the Quality Data Shows

  PCAB accreditation research: what published quality and sterility data actually show about accredited versus non-accredited compounding pharmacies today.

• PCAB accreditation vs USP 795/797 compliance: what each covers

  PCAB accreditation and USP 795/797 compliance are not the same thing. Here is what each one covers, how they overlap, and why both matter for pharmacy quality.

• PCAB vs USP: two compounding-quality frameworks

  PCAB is an accreditation; USP sets the standards. Here is the difference between PCAB and USP compounding chapters and why both matter for pharmacy quality.

• Peptide purity: what a COA can and cannot confirm

  A peptide certificate of analysis tells you a lot — and leaves a lot out. Here is what HPLC and mass-spec actually confirm, and what they do not.

• Peptide therapy and the compounding model: how it all fits together

  How does a peptide actually get from a research compound to your medicine cabinet? A plain-English explanation of the prescription, compounding, and dispensing model.

• Red flags on a peptide website: a checklist

  Eight red flags that signal a peptide website is gray-market or unsafe — and what a legitimate path looks like. Consumer-protection checklist.

• Research-use-only vs physician-supervised peptides

  Research-use-only peptides are sold for the lab bench, not for people. Here is how they differ from physician-supervised compounded peptides, in plain English.

• Single-dose vs multi-dose vials: what the difference means

  The difference between single-dose and multi-dose vials is a preservative. See which you discard after one use and the rules for reusing a multi-dose vial.

• Single-vial peptide combinations: which ones work together

  Not all peptides can be combined in one vial. Here's what determines compatibility — pH, diluent stability, dosing schedules — and which combinations are industry-established.

• Single-vial vs multi-vial peptide combinations: a clinical perspective

  Can two peptides be combined in one vial? Here is how compounding pharmacies decide, what the stability data has to support, and what patients should ask.

• State pharmacy board vs FDA: who oversees compounding

  Compounding has two overseers: state pharmacy boards license the pharmacy day-to-day, the FDA sets federal rules for which substances may be compounded.

• Sterile filtration: how a 0.22-micron filter works

  Sterile filtration removes bacteria without heat using 0.22 micron pores, about 1/300th the width of a hair. See the FDA test a filter must pass to qualify.

• Sterility and Endotoxin Testing in Compounding Pharmacies

  Sterility and endotoxin testing are two separate checks: one confirms an injectable grows no microbes, the other that it carries no fever-causing fragments.

• Sterility testing in compounded peptides: what the standards require

  Compounded injectable peptides must meet USP <797> sterility standards. Here is what the standards require — and what to look for in a 503A pharmacy.

• Terminal vs aseptic sterilization: the difference

  Terminal sterilization sterilizes a drug after it is sealed; aseptic processing keeps it sterile while filling. Here's the difference and which the FDA prefers.

• The certificate of analysis: how to read a peptide pharmacy's quality paperwork

  A certificate of analysis is the receipt for what is in your peptide vial. Here is how to read one, what to look for, and which fields actually matter.

• Third-party testing for peptides: what verification actually looks like

  Third-party testing verifies peptide identity, purity, and sterility. Here is what a real certificate of analysis includes and how to tell genuine verification from marketing.

• Tonicity agents in injectables explained

  Tonicity agents make an injection match the body's salt balance so it does not damage cells. Here is what they are, why they matter, and the science.

• USP 795 vs USP 797: the two compounding standards a quality pharmacy follows

  USP 795 vs 797: 795 covers nonsterile compounding like creams and capsules, 797 covers sterile injectables. See what 797 adds and why peptide shots need it.

• Vial coring: what it is and how to prevent it

  Vial coring is when a needle shaves rubber from the stopper into the vial. See what causes it, why test rates ran from 0% to 49%, and the bevel-up fix.

• Water for injection: pharmaceutical water grades

  Water for injection is ultra-pure water made for injectable drugs. See the 3 grades, from WFI to sterile and bacteriostatic water, and when each one is used.

• What 'research-use only' on a peptide vial actually means

  Research-use only on a peptide vial, in plain English — what the label really means, what it does not, and why it is not a clinical pathway for patients.

• What "research-use only" on a peptide vial actually means

  A research-use-only label is not a wink-and-nod prescription. Here is what RUO actually means, who can legally buy these vials, and why the label is a warning.

• What happens inside a compounding pharmacy

  A walkthrough of what actually happens inside a 503A compounding pharmacy — from the active pharmaceutical ingredient to the labeled vial — in plain English.

• What PCAB accreditation does not cover: the realistic limits

  PCAB accreditation checks a compounding pharmacy's processes — not every batch's potency. Here is what it verifies and what it cannot tell you.

• What PCAB accreditation means for compounding pharmacy quality

  PCAB accreditation is a voluntary on-site audit of compounding pharmacies against USP 797 and 800. See what surveyors check, how often, and how to verify it.

• What telehealth peptide prescribing actually looks like

  Online peptide therapy should follow the steps of any prescription: intake, labs, physician review, then a licensed pharmacy. See each step and what to ask.

• Who ensures compounding pharmacy quality and how

  State boards, USP 797, PCAB accreditation, and FDA inspection authority all shape compounding pharmacy quality. Here is how each layer works.

• Who should care about PCAB accreditation and why

  PCAB accreditation explained — what it is, who it matters to, and what it actually tells you about a compounding pharmacy's quality standards.

• Who uses 503A compounding pharmacies and why

  503A compounding pharmacies serve a specific population — patients who cannot use commercially available drugs. Here is who they serve and why the model exists.

• Why 503A pharmacies exist: the oversight history

  503A pharmacies exist because of a 1997 law, a 2002 Supreme Court ruling, and the 2012 NECC meningitis outbreak that forced Congress to pass the DQSA in 2013.

• Why a compounded medication is not a generic drug

  Compounded and generic drugs are often confused, but they follow different rules. Here is the plain-English difference and why it matters for you.

• Why peptide vials are nitrogen-flushed: oxidation, explained

  Nitrogen flushing removes oxygen from the vial headspace before sealing. Here's why that step protects peptide integrity and what oxidation actually does.